GRDN — Guardian Pharmacy Services Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMid CapNeutral

Annual income statement for Guardian Pharmacy Services, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	736	792	909	1,046	1,228
Cost of Revenue
Gross Profit	147	161	186	208	244
Selling / General / Administrative Expenses
Depreciation and Amortization
Total Operating Expenses	703	762	857	1,005	1,291
Operating Profit	32.9	30.1	52	40.9	-62.9
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	29.7	28.3	49.7	37.7	-66.5
Provision for Income Taxes
Net Income After Taxes	29.7	28.3	49.7	37.7	-71
Minority Interest
Net Income Before Extraordinary Items
Net Income	19.9	16.3	35.4	23.9	-87.3
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	19.9	16.3	35.4	0	-110
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.321	0.263	0.57	0	-1.77